LUNDBECK LLC for LUNDBECK LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 25, 2010 | $254,340 | Replaced |
| 4th Quarter - Report | Jan 25, 2010 | $254,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies, 340b discounts S. 301 - physicians payments transparency; preemption
Foreign entity interest: Understanding the impact of health reform on smaller global company and assuring continued access to orphan specialty medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.